Keyphrases
Adverse Effects
37%
Alendronate
100%
Aminobisphosphonates
25%
Bleeding
12%
Bone Resorption
12%
Endoscopic Findings
12%
Esophageal Disorders
12%
Esophageal Wall
12%
Esophagitis
100%
Esophagus
12%
Exudative Inflammation
12%
Female Disease
12%
First Foods
12%
Intestinal mucosa
12%
Lying down
12%
Merck
12%
Osteoclast
12%
Osteoporosis
12%
Paget's Disease of Bone
12%
Post-marketing Surveillance
12%
Postmenopausal Women
12%
Selective Inhibitor
12%
Stomach
12%
Symptom Onset
12%
Upper Gastrointestinal Tract
12%
Medicine and Dentistry
Adverse Event
37%
Alendronic Acid
100%
Bleeding
12%
Esophageal Disorder
12%
Esophagitis
100%
Esophagus
12%
Gastrointestinal Mucosa
12%
Ingestion
12%
Osteoclast
12%
Osteolysis
12%
Osteoporosis
12%
Paget Bone Disease
12%
Postmenopause
12%
Venous Ulcer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
37%
Alendronic Acid
100%
Bleeding
12%
Disease
12%
Esophagitis
100%
Inflammation
12%
Paget Bone Disease
12%
Postmarketing Surveillance
12%
Tablet
25%
Ulcer
25%